Diabetes technology

Does fully closed‐loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta‐analysis of randomized controlled trials

Diabet MedPublished Systematic review and meta-analysis of randomised trials

Pooled result · Time in target glucose range per 24 hResult — go to the resultMD 23.39 % 95% CI 16.64%–30.14%

Authors' conclusion

Our meta-analysis suggests that fully closed-loop AID may improve glycaemic control in patients with type 2 diabetes, particularly for those with more challenging diabetes management. Further research is required to establish the feasibility of implementing these systems in clinical practice. [Correction added on 26 August 2023 after first online publication: Under Results, the first sentence "We included seven RCTs (three crossover and one parallel designs)" has been changed to "We included seven RCTs (three crossover and four parallel designs)".].

Study context

Population
Patients with T2D; Randomized Controlled Trials (RCTs) from PubMed, Scopus, Web of Science and Cochrane Central to April 26, 2023
Participants
390 patients7 RCTs
Comparison
Fully closed-loop automated insulin delivery (AID) vs conventional insulin therapy
Outcome
Proportion of time in target glucose range (5.6-10 mmol/L, 3.9-10 mmol/L, or 3.9-8 mmol/L, depending on the study)
Methodological detailsrandom effect model, three crossover and four parallel design RCTs
  • Random effect model
  • Three crossover and four parallel design RCTs

Pooled result

Time in target glucose range per 24 h

MD

23.39 %

95% CI 16.64%–30.14%

P < 0.01

Fully closed-loop AIDvs Conventional insulin therapy
MD 23.39 % (95% CI 16.64%–30.14%); P < 0.01

As reported in the abstract

Further pooled results

OutcomeMD (%) (95% CI)P value
Proportion of time in target glucose range, overnightAdditional 108 min overnight · random effect model22.40 (12.88%–31.91%)P < 0.01
Proportion of time in target glucose range, daytimeAdditional 258 min during the daytime · random effect model26.85 (21.06%–32.63%)P < 0.01

Overall time in hyperglycaemia · per 24 h

Overall time in hyperglycaemia vs control: shortened by 326 min per 24 h
MD = −22.67%, 95% CI [−30.87%, −14.46%], p < 0.01
  • Random effect model

Time in hypoglycaemia (overall, overnight, daytime)

No significant difference between the two groups in overall, overnight and daytime periods spent in hypoglycaemia

Safety

No significant difference between the two groups in overall, overnight and daytime time in hypoglycaemia

Original publication

Does fully closed‐loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta‐analysis of randomized controlled trials. Diabet Med. Published 18 August 2023. doi:10.1111/dme.15196

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.